OpGen - 9 Year Stock Price History | OPGN
- The all-time high OpGen stock closing price was 48500.00 on May 05, 2015.
- The OpGen 52-week high stock price is 3.84, which is 683.7% above the current share price.
- The OpGen 52-week low stock price is 0.17, which is 65.3% below the current share price.
- The average OpGen stock price for the last 52 weeks is 0.51.
OpGen Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 0.4874 | 0.4272 | 0.7800 | 0.2536 | 0.4916 | 17.05% |
2023 | 0.8521 | 3.3760 | 3.4600 | 0.1700 | 0.4200 | -85.11% |
2022 | 10.4969 | 21.6000 | 22.2000 | 2.4000 | 2.8200 | -85.90% |
2021 | 45.9104 | 43.0000 | 71.6000 | 19.9100 | 20.0000 | -50.98% |
2020 | 42.6156 | 23.1300 | 80.8000 | 22.8000 | 40.8000 | 80.53% |
2019 | 227.6110 | 573.4000 | 720.0000 | 20.4000 | 22.6000 | -95.65% |
2018 | 829.9991 | 1867.0000 | 2628.0000 | 360.0000 | 520.0000 | -72.16% |
2017 | 6354.8682 | 12000.0000 | 15000.0000 | 1580.0000 | 1868.0000 | -83.76% |
2016 | 15235.3611 | 17634.0000 | 37000.0000 | 8900.0000 | 11500.0000 | -39.47% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.006B | $0.003B |
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $123.165B | 15.45 |
Cencora (COR) | United States | $44.692B | 17.42 |
ICON (ICLR) | Ireland | $25.998B | 24.54 |
DiDi Global (DIDIY) | China | $24.302B | 0.00 |
Avantor (AVTR) | United States | $16.893B | 24.87 |
CochLear (CHEOY) | Australia | $14.118B | 0.00 |
Viatris (VTRS) | United States | $14.074B | 4.05 |
Revvity (RVTY) | United States | $12.701B | 22.25 |
Medpace Holdings (MEDP) | United States | $12.416B | 40.85 |
Charles River Laboratories (CRL) | United States | $12.119B | 22.09 |
Natera (NTRA) | United States | $11.739B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.436B | 0.00 |
Solventum (SOLV) | United States | $11.160B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.373B | 0.00 |
HealthEquity (HQY) | United States | $6.801B | 50.81 |
Organon (OGN) | United States | $5.318B | 5.04 |
Bausch + Lomb (BLCO) | Canada | $5.074B | 20.34 |
Doximity (DOCS) | United States | $4.589B | 34.17 |
PACS (PACS) | United States | $3.743B | 0.00 |
Surgery Partners (SGRY) | United States | $3.254B | 30.12 |
Sotera Health (SHC) | United States | $3.196B | 15.68 |
Progyny (PGNY) | United States | $3.114B | 52.26 |
GoodRx Holdings (GDRX) | United States | $2.951B | 149.40 |
Life Times (LTH) | United States | $2.907B | 30.79 |
Premier (PINC) | United States | $2.483B | 9.09 |
AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
Teladoc Health (TDOC) | United States | $2.169B | 0.00 |
Agilon Health (AGL) | United States | $1.985B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.955B | 0.00 |
NovoCure (NVCR) | Jersey | $1.673B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.493B | 0.00 | |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
Pediatrix Medical (MD) | United States | $0.780B | 8.07 |
QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
Embecta (EMBC) | United States | $0.598B | 3.95 |
InnovAge Holding (INNV) | United States | $0.587B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.533B | 0.00 |
CareDx (CDNA) | United States | $0.527B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.510B | 0.00 |
LifeMD (LFMD) | United States | $0.509B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.497B | 0.00 |
Enhabit (EHAB) | United States | $0.495B | 44.82 |
Sonida Senior Living (SNDA) | United States | $0.449B | 0.00 |
MultiPlan (MPLN) | United States | $0.429B | 0.00 |
Beauty Health (SKIN) | United States | $0.423B | 0.00 |
DocGo (DCGO) | United States | $0.385B | 61.67 |
ModivCare (MODV) | United States | $0.381B | 7.12 |
Sera Prognostics (SERA) | United States | $0.322B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
Sharecare (SHCR) | United States | $0.261B | 0.00 |
Biodesix (BDSX) | United States | $0.174B | 0.00 |
So-Young (SY) | China | $0.128B | 43.00 |
Oncology Institute (TOI) | United States | $0.070B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.069B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
NeueHealth (NEUE) | United States | $0.051B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
OncoCyte (OCX) | United States | $0.023B | 0.00 |
DermTech (DMTK) | United States | $0.022B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
Assure Holdings (IONM) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |